Trials

SciClone Reports Financial Results for the First Quarter 2012

FOSTER CITY, CA: ZADAXIN(R) Revenues Increased 37% Year Over Year ...

Agennix AG Schedules Conference Call on May 9 to Discuss First Quarter 2012 Financial Results

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: ...

Cytokinetics to Announce First Quarter Results on April 26, 2012

SOUTH SAN FRANCISCO, CA: ...

Peregrine Launches PS-Targeting Clinical Imaging Program

TUSTIN, CA: Investigational New Drug Application Filed With the FDA to Advance Lead Imaging Candidate 124I-PGN650 Into Clinical Development; AACR Presentation Shows Increased Exposure of Phosphatidylserine (PS) F ...

Threshold Pharmaceuticals Announces Multiple Data Presentations on TH-302 at the 2012 AACR Annual Meeting

SOUTH SAN FRANCISCO, CA: Oral, Late-Breaking Presentation and Subsequent Webcast to Detail Efficacy and Safety Data From Phase 2b Trial of TH-302 in Pancreatic Cancer ...

WorldCare Clinical, in Conjunction With the Massachusetts General Hospital (MGH) Department of Radiology, Announces the Imaging Biomarkers in Clinical Trials Conference

BOSTON, MA: ...

WorldCare Clinical Expands Capabilities With Introduction of New Service Offering for Cardiovascular Endpoint Committees

BOSTON, MA: ...

Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis

PLANEGG, GERMANY and MUNICH, GERMANY: ...

Bioanalytical Systems to Present at the Sidoti & Company Semiannual Micro-Cap Conference, Monday, January 9, at 4:00 p.m. EST

WEST LAFAYETTE, IN: ...

Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines

LEXINGTON, MA and MOSCOW: Agreement Covers the Launch of the Oncophage(R) Vaccine, Approved in Russia ...